Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging LS Steelman, WH Chappell, SL Abrams, CR Kempf, J Long, P Laidler, ... Aging (Albany NY) 3 (3), 192, 2011 | 821 | 2011 |
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health WH Chappell, LS Steelman, JM Long, RC Kempf, SL Abrams, RA Franklin, ... Oncotarget 2 (3), 135, 2011 | 688 | 2011 |
Intolerance of cow's milk and chronic constipation in children G Iacono, F Cavataio, G Montalto, A Florena, M Tumminello, M Soresi, ... New England Journal of Medicine 339 (16), 1100-1104, 1998 | 595 | 1998 |
GSK-3 as potential target for therapeutic intervention in cancer JA McCubrey, LS Steelman, FE Bertrand, NM Davis, M Sokolosky, ... Oncotarget 5 (10), 2881, 2014 | 552 | 2014 |
Epidemiology, risk factors, and natural history of hepatocellular carcinoma G Montalto, M Cervello, L Giannitrapani, F Dantona, A Terranova, ... Annals of the New York Academy of Sciences 963 (1), 13-20, 2002 | 496 | 2002 |
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response JA McCubrey, LS Steelman, WH Chappell, SL Abrams, G Montalto, ... Oncotarget 3 (9), 954, 2012 | 381 | 2012 |
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance JA McCubrey, LS Steelman, WH Chappell, SL Abrams, RA Franklin, ... Oncotarget 3 (10), 1068, 2012 | 369 | 2012 |
Sex hormones and risk of liver tumor L Giannitrapani, M Soresi, E La Spada, M Cervello, N D'alessandro, ... Annals of the New York Academy of Sciences 1089 (1), 228-236, 2006 | 361 | 2006 |
Gastroesophageal reflux and cow's milk allergy in infants: a prospective study G Lacono, A Carroccio, F Cavataio, G Montalto, I Kazmierska, D Lorello, ... Journal of allergy and clinical immunology 97 (3), 822-827, 1996 | 354 | 1996 |
Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial A Mangia, N Minerva, D Bacca, R Cozzolongo, GL Ricci, V Carretta, ... Hepatology 47 (1), 43-50, 2008 | 340 | 2008 |
Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children A Carroccio, G Iacono, M Cottone, L Di Prima, F Cartabellotta, F Cavataio, ... Clinical chemistry 49 (6), 861-867, 2003 | 338 | 2003 |
Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents V Calvaruso, G Cabibbo, I Cacciola, S Petta, S Madonia, A Bellia, F Tinè, ... Gastroenterology 155 (2), 411-421. e4, 2018 | 336 | 2018 |
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention NM Davis, M Sokolosky, K Stadelman, SL Abrams, M Libra, S Candido, ... Oncotarget 5 (13), 4603, 2014 | 326 | 2014 |
Celiac disease in the developing countries: a new and challenging public health problem F Cataldo, G Montalto World journal of gastroenterology: WJG 13 (15), 2153, 2007 | 284 | 2007 |
Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention JA McCubrey, LS Steelman, FE Bertrand, NM Davis, SL Abrams, ... Leukemia 28 (1), 15-33, 2014 | 281 | 2014 |
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. M Soresi, C Magliarisi, P Campagna, G Leto, G Bonfissuto, A Riili, ... Anticancer research 23 (2C), 1747-1753, 2003 | 276 | 2003 |
Intolerance to hydrolysed cow's milk proteins in infants: clinical characteristics and dietary treatment A Carroccio, F Cavataio, G Montalto, D D'amico, L Alabrese, G Iacono Clinical & Experimental Allergy 30 (11), 1598-1603, 2000 | 269 | 2000 |
Cyclooxygenases in hepatocellular carcinoma M Cervello, G Montalto World journal of gastroenterology: WJG 12 (32), 5113, 2006 | 229* | 2006 |
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs JA McCubrey, K Lertpiriyapong, LS Steelman, SL Abrams, LV Yang, ... Aging (Albany NY) 9 (6), 1477, 2017 | 223 | 2017 |
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways JA McCubrey, LS Steelman, CR Kempf, WH Chappell, SL Abrams, ... Journal of cellular physiology 226 (11), 2762-2781, 2011 | 221 | 2011 |